Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lantheus Medical Imaging
The purpose of this clinical research study is to determine how well CARDIOLITE® rest and stress myocardial (heart) imaging can define the pediatric Kawasaki disease (KD) population into high and low risk categories of developing cardiac (heart) events (complications) from 1 year through 3 years after image completion. The safety of CARDIOLITE® rest and stress heart imaging will also be studied.
Age
4–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females between 4 and 16
Meet the epidemiological definition of Kawasaki Disease or have a diagnosis of incomplete KD, including evidence of coronary artery disease as determined by their physician.
Be able to exercise adequately to achieve 85% age predicted maximum heart rate
You may not be if
Terminal illness where expected survival is \< 6 months
Clareo Health | A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
